Exactech Inc. (EXAC) Updates Q4 Earnings Guidance
Exactech Inc. (NASDAQ:EXAC) issued an update on its fourth quarter earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.30-0.32 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.31, ARN reports. The company issued revenue guidance of $61.5-63.5 million, compared to the consensus revenue estimate of $63.05 million.
Several analysts have recently commented on the stock. Analysts at Thomson Reuters/Verus upgraded shares of Exactech from a hold rating to a buy rating in a research note to investors on Monday, September 16th. Analysts at Canaccord Genuity raised their price target on shares of Exactech from $28.00 to $29.00 in a research note to investors on Thursday, July 25th. They now have a buy rating on the stock.
Exactech Inc. (NASDAQ:EXAC) traded up 3.25% on Tuesday, hitting $21.93. 96,334 shares of the company’s stock traded hands. Exactech Inc. has a 52 week low of $15.01 and a 52 week high of $22.12. The stock’s 50-day moving average is $19.84 and its 200-day moving average is $19.34. The company has a market cap of $295.8 million and a price-to-earnings ratio of 20.40.
Exactech (NASDAQ:EXAC) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.21 by $0.02. The company had revenue of $55.70 million for the quarter, compared to the consensus estimate of $55.36 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Analysts expect that Exactech Inc. will post $1.08 EPS for the current fiscal year.
Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.